Disturbed sleep and nocturnal altered breathing are related to disturbances of glucose metabolism. The present uncontrolled observational study explores the role of these factors on the variability of fasting glycemia.
Methods:
The number and duration of nocturnal awakenings and the fasting glycemia of 97 patients with type 2 diabetes treated with diet, metformin, or gliptins were recorded over seven consecutive days. During the same time period, the main respiratory indexes—oxygen disturbance index, apnea/hypopnea index, and respiratory disturbance index—were recorded for one night.
Results:
The three respiratory indexes and the number of nocturnal awakenings are highly correlated with the coefficient of variation of the fasting blood glucose recorded over the 7-day period at p < .005 level. A multiple regression analysis showed that the variables in the model explained 86% of the variability.
Discussion:
Respiratory/sleep disturbances appear to be modulators superimposed on blood glucose levels determined by other factors.
HirschIBBrownleeM. Should minimal blood glucose variability become the gold standard of glycemic control?J Diabetes Complications.2005; 19 (3): 178–81.
2.
The Diabetes Control and Complications Trial Research Group. The relationship of glycaemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes.1995; 44 (8): 968–83.
3.
Gimeno-OrnaJACastro-AlonsoFJBoned-JulianiBLou-ArnalLM. Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients. J Diabetes Complications.2003; 17 (2): 78–81.
4.
BragdJAdamsonUBäcklundLBLinsPEMobergEOskarssonP. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?Diabetes Metab.2008; 34 (6 Pt 1): 612–6.
5.
KilpatrickES. Arguments for and against the Role of Glucose Variability in the Development of Diabetes Complications. J Diabetes Sci Technol.2009; 3 (4): 649–55.
6.
DefronzoRA. Banting Lecture. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes.2009; 58 (4): 773–95.
ThorensB. Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes Metab.2011; 13Suppl 1: 82–8.
9.
SpiegelKLeproultRVan CauterE. Impact of sleep debt on metabolic and endocrine function. Lancet.1999; 354 (9188): 1435–9.
10.
SeiceanSKirchnerHLGottliebDJPunjabiNMResnickHSandersMBudhirajaRSingerMRedlineS. Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: The Sleep Heart Health Study. Diabetes Care.2008; 31 (5): 1001–6.
11.
TasaliEMokhlesiBVan CauterE. Obstructive sleep apnea and type 2 diabetes: Interacting epidemics. Chest.2008; 133 (2): 496–506.
12.
ElmasryALindbergEHednerJJansonCBomanG. Obstructive sleep apnoea and urine catecholamines in hypertensive males: A population-based study. Eur Respir J.2002; 19 (3): 511–7.
PatelSASlivkaWASciurbaFC. Validation of a wearable body monitoring device in COPD. Am J Respir Crit Care Med.2004; 30: A771.
15.
PatelSASciurbaFC. Emerging concepts in outcome assessment for COPD clinical trials. Semin Respir Crit Care Med.2005; 26 (2): 253–62.
16.
Jean-LouisGKripkeDFMasonWJElliottJAYoungstedtSD. Sleep estimation from wrist movement quantified by different actigraphic modalities. J Neurosci Methods.2001; 105 (2): 185–91.
17.
RodbardD. Clinical interpretation of indices of quality of glycemic control and glycemic variability. Postgrad Med.2011; 123 (4): 107–18.
18.
SilverbergDSOksenbergAIainaA. Sleep related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, underdiagnosed, and undertreated. Am J Hypertens.1997; 10 (12 Pt 1): 1319–25.
19.
NietoFJYoungTBLindBKShaharESametJMRedlineSDágostinoRBNewmanABLebowitzMDPickeringTG. Association of sleep-disordered breathing, sleep apnoea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA.2000; 283 (14): 1829–36.
20.
HungJWhitfordEGParsonsRWHillmanDR. Association of sleep apnoea with myocardial infarction in men. Lancet.1990; 336 (8710): 261–4.
21.
DykenMESomersVKYamadaTRenZYZimmermanMB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke.1996; 27 (3): 401–7.
22.
RodbardD. The challenges of measuring glycaemic variability. J Diabetes Sci Technol.2012; 6 (3): 712–5.
23.
MuggeoMVerlatoGBonoraECianiFMoghettiPEastmanRCrepaldiGde MarcoR. Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: The Verona Diabetes Study. Diabetologia.1995; 38 (6): 672–9.
24.
McCowenKCMalhotraABistrianBR. Stress-induced hyperglycemia. Crit Care Clin.2001; 17 (1): 107–24.
